awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q57106864-D2316C62-26F9-4C0D-9102-43E984A11533
Q57106864-D2316C62-26F9-4C0D-9102-43E984A11533
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57106864-D2316C62-26F9-4C0D-9102-43E984A11533
Novel treatment strategies for patients with HER2-positive breast cancer who do not benefit from current targeted therapy drugs
P2860
Q57106864-D2316C62-26F9-4C0D-9102-43E984A11533
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57106864-D2316C62-26F9-4C0D-9102-43E984A11533
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7cff7a3431dbcf3f6ffbb4b7ef6e2a3d4e145dba
P2860
Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells.